[ad_1]
San Diego, July 3, 2021 /PRNewswire/ – Johnson Fistel, LLP, a shareholder’s equity law firm, announced that it represented Athira Pharma, Inc. (“Athira” or “Company”) (NASDAQ:Atta).The class action represents shareholders who purchased Athira’s common stock based on or can be traced back to September 2020 Initial public offering (“IPO”). If you wish to serve as the lead plaintiff in this class action, you must August 24, 2021.
[click here to join this action]
In or about September 18, 2020, Athira sold 12 million shares in its initial public offering (“IPO”) 17 USD One share, raise about 204,000,000 USD In the new capital. The complaint stated that the registration statement was prepared due to negligence and therefore contains untrue statements about important facts, omitting…
The full story on Benzinga.com
[ad_2]
Source link
